Showing results (281-290 of 946) with videos related to
Sort By:
Pageof 95
Annales D'Immunologie|January 1, 1977
[Determination of anti-DNA and anti-RNA antibodies in serum and CSF by a new counterimmunoelectrophoresis method]E Schuller, N Delasnerie, J Reboul, et al.Journal of Neurochemistry|September 1, 1992
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?A Kastner, E C Hirsch, O Lejeune, et al.Dementia and Geriatric Cognitive Disorders|January 1, 1997
Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's diseaseF Boissière, S Hunot, B Faucheux, et al.The European Journal of Neuroscience|December 21, 2000
Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patientsC Jan, C François, D Tandé, et al.Brain Research|December 5, 1983
Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brainH Taquet, F Javoy-Agid, M Hamon, et al.Journal of Neurochemistry|July 29, 1998
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's diseaseF Boissière, B Faucheux, C Duyckaerts, et al.Acta Neuropathologica|January 1, 1996
Progressive supranuclear palsy: a clinicopathological study of 21 casesM Verny, K A Jellinger, J J Hauw, et al.Brain Research|November 19, 1993
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortemJ Villares, B Faucheux, O Strada, et al.Neuroscience|January 1, 1991
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.Neuroscience|January 1, 1990
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization studyF Javoy-Agid, E C Hirsch, S Dumas, et al.Pageof 95